Literatura académica sobre el tema "Cardioprotective"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Cardioprotective".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Cardioprotective"
Atwal, Kamail S. y Gary J. Grover. "Treatment of Myocardial Ischemia with ATP-Sensitive Potassium Channel (KATP) Openers". Current Pharmaceutical Design 2, n.º 5 (octubre de 1996): 585–95. http://dx.doi.org/10.2174/1381612802666221004183709.
Texto completoGupta, I., A. Goyal, NK Singh, HN Yadav y PL Sharma. "Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart". Human & Experimental Toxicology 36, n.º 8 (12 de octubre de 2016): 867–75. http://dx.doi.org/10.1177/0960327116673169.
Texto completoHuh, Joon, Garrett J. Gross, Hiroshi Nagase y Bruce T. Liang. "Protection of cardiac myocytes via δ1-opioid receptors, protein kinase C, and mitochondrial KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 280, n.º 1 (1 de enero de 2001): H377—H383. http://dx.doi.org/10.1152/ajpheart.2001.280.1.h377.
Texto completoGross, Eric R., Jason N. Peart, Anna K. Hsu, John A. Auchampach y Garrett J. Gross. "Extending the cardioprotective window using a novel δ-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway". American Journal of Physiology-Heart and Circulatory Physiology 288, n.º 6 (junio de 2005): H2744—H2749. http://dx.doi.org/10.1152/ajpheart.00918.2004.
Texto completoSchultz, Jo El J., Anna K. Hsu, Hiroshi Nagase y Garrett J. Gross. "TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/oproteins and KATPchannels". American Journal of Physiology-Heart and Circulatory Physiology 274, n.º 3 (1 de marzo de 1998): H909—H914. http://dx.doi.org/10.1152/ajpheart.1998.274.3.h909.
Texto completoIntachai, Kannaporn, Siriporn C. Chattipakorn, Nipon Chattipakorn y Krekwit Shinlapawittayatorn. "Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury". International Journal of Molecular Sciences 19, n.º 9 (21 de agosto de 2018): 2466. http://dx.doi.org/10.3390/ijms19092466.
Texto completoPyle, W. Glen, Yi Chen y Polly A. Hofmann. "Cardioprotection through a PKC-dependent decrease in myofilament ATPase". American Journal of Physiology-Heart and Circulatory Physiology 285, n.º 3 (septiembre de 2003): H1220—H1228. http://dx.doi.org/10.1152/ajpheart.00076.2003.
Texto completoTonkovic-Capin, Marija, Garrett J. Gross, Zeljko J. Bosnjak, James S. Tweddell, Colleen M. Fitzpatrick y John E. Baker. "Delayed cardioprotection by isoflurane: role of KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 283, n.º 1 (1 de julio de 2002): H61—H68. http://dx.doi.org/10.1152/ajpheart.01040.2001.
Texto completoZhang, Jimmy, Sergiy M. Nadtochiy, William R. Urciuoli y Paul S. Brookes. "The cardioprotective compound cloxyquin uncouples mitochondria and induces autophagy". American Journal of Physiology-Heart and Circulatory Physiology 310, n.º 1 (1 de enero de 2016): H29—H38. http://dx.doi.org/10.1152/ajpheart.00926.2014.
Texto completoLiu, Shu Q., Brandon J. Tefft, Derek T. Roberts, Li-Qun Zhang, Yupeng Ren, Yan Chun Li, Yong Huang, Di Zhang, Harry R. Phillips y Yu H. Wu. "Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia". American Journal of Physiology-Heart and Circulatory Physiology 303, n.º 12 (15 de diciembre de 2012): H1446—H1458. http://dx.doi.org/10.1152/ajpheart.00362.2012.
Texto completoTesis sobre el tema "Cardioprotective"
Simpkin, J. C. "Apelin : a cardioprotective adipocytokine". Thesis, University College London (University of London), 2007. http://discovery.ucl.ac.uk/1445937/.
Texto completoDaubney, J. "The cardioprotective mechanisms of dietary flavonoids". Thesis, Nottingham Trent University, 2015. http://irep.ntu.ac.uk/id/eprint/27927/.
Texto completoMuraski, John A. "The cardioprotective effects of Pim-1 kinase". Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2007. http://wwwlib.umi.com/cr/ucsd/fullcit?p3310011.
Texto completoTitle from first page of PDF file (viewed September 4, 2007). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references (p. 90-103).
Hassan, Lobna Mohammed Saber Abdel. "Intracellular mechanisms of action of cardioprotective agents". Thesis, University of Sunderland, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.338350.
Texto completoMcCafferty, Kieran. "Novel cardioprotective strategies for the uraemic heart". Thesis, Queen Mary, University of London, 2011. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8725.
Texto completoPoolman, Toryn. "Investigations into the cardioprotective properties of resveratrol". Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29695.
Texto completoWright, Denis Matthew John y mikewood@deakin edu au. "Potential antiarrhythmic and cardioprotective agents based on adenosine". Deakin University. School of Biological and Chemical Sciences, 1998. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050915.160941.
Texto completoSopizhenko, Nadia. "Properties of cardioprotective preparations and their antistress effect". Thesis, Київський національний університет технологій та дизайну, 2019. https://er.knutd.edu.ua/handle/123456789/13167.
Texto completoBarbalace, Maria Cristina <1988>. "17β-estradiol modulates cardioprotective effects of nutraceutical compounds". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2018. http://amsdottorato.unibo.it/8526/1/Barbalace_Maria_Cristina_tesi.pdf.
Texto completoMaarman, Gerald Jerome. "Melatonin as a novel cardioprotective therapy in pulmonary hypertension". Doctoral thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/12872.
Texto completoPulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure which leads to right ventricular hypertrophy and failure. The mechanism involved in the pathophysiology of the disease remains unclear but it is suggested that oxidative stress may trigger cardiovascular dysfunction associated with the disease. To date, there is no efficient therapy against PH and novel therapies are urgently needed. Melatonin is a powerful antioxidant that can confer benefit against ischemia-reperfusion injury and hypertension. We therefore hypothesised that melatonin may confer cardiovascular benefits against PH. Methods: Oxidative stress (plasma lipid peroxidation, antioxidant capacity and antioxidant enzyme activity) was assessed in healthy (n=10), in patients with PH (n=10), in Long Evans rats (n≥6) or in a rat model of PH induced 28 days after the injection of monocrotaline (MCT, 80mg/kg, subcutaneous) (n≥6). Melatonin (75ng/L, nutritional concentration), 4mg/kg or 6mg/kg (therapeutic dose) was given daily in the drinking water of rats, with the treatment started 5 days before the injection of MCT, on the day of the injection or 14 days after the injection of MCT. The development of PH was measured by assessing right ventricular hypertrophy, cardiac fibrosis, oxidative stress and cardiac function (via echocardiography and the isolated heart Langendorff perfusion model). Results: Plasma oxidative stress was increased in both patients and rats with PH compared with their respective controls. A chronic treatment with melatonin (75ng/L, 4mg/kg or 6mg/kg) starting on the day of the injection with MCT in rats with PH reduced right ventricular hypertrophy, cardiac dysfunction and plasma oxidative stress compared with control rats. Furthermore, the beneficial effect of melatonin (6mg/kg) could be observed when given as a preventive (5 days prior to the injection of MCT) or as a curative therapy (14 days after the injection of MCT). Conclusions: Our data demonstrate that chronic treatment of melatonin confers cardioprotection in a rat model of PH. As melatonin is inexpensive, safe (no reported side effects) and already available over the counter in many countries, we propose that melatonin should be considered as a novel preventive/curative therapy to limit cardiac dysfunction in patients with PH.
Libros sobre el tema "Cardioprotective"
Kendall, Martin J. Preventing coronary artery disease: Cardioprotective therapeutics in practice. 2a ed. London: Martin Dunitz, 1998.
Buscar texto completoM, Beale C., ed. The cardioprotective role of HRT: A clinical update. New York: Parthenon Pub. Group, 1996.
Buscar texto completo(Germany)), Freiburg Focus on Biomeasurement (9th 1995 Freiburg im Breisgau. Pharmacological evaluation of cardioprotective substances: Experimental induction and indicators of myocardial injury and myocardial protection. Buchenbach, Germany: Gesellschaft für Erfahrungstransfer in der Biomesstechnik e.V., 1996.
Buscar texto completoCardioprotection. Oxford: Oxford University Press, 2009.
Buscar texto completoInternational Symposium, Calcium Antagonists in Cardiovascular Care (1991 : Basle, Switzerland), ed. Verapamil-- a cardioprotective strategy: Highlights from a satellite symposium to the International Symposium, Calcium Antagonists in Cardiovascular Care, Basle, Switzerland, Feb. 13, 1991. New York, NY: Raven Health Care Communications, 1991.
Buscar texto completoMinatoguchi, Shinya. Cardioprotection Against Acute Myocardial Infarction. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-15-0167-8.
Texto completoBaxter, G. F. y D. M. Yellon, eds. Delayed Preconditioning and Adaptive Cardioprotection. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-5312-6.
Texto completoF, Baxter G. y Yellon Derek M, eds. Delayed preconditioning and adaptive cardioprotection. Dordrecht: Kluwer Academic Publishers, 1998.
Buscar texto completoMentzer, Robert M., Masafumi Kitakaze, James M. Downey y Masatsugu Hori, eds. Adenosine, Cardioprotection and Its Clinical Application. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4419-8736-5.
Texto completoM, Mentzer Robert, ed. Adenosine, cardioprotection, and its clinical application. Boston: Kluwer Academic Publishers, 1997.
Buscar texto completoCapítulos de libros sobre el tema "Cardioprotective"
Prasad, Abhiram y Bernard John Gersh. "Endogenous Cardioprotective Strategies". En Management of Myocardial Reperfusion Injury, 239–60. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84996-019-9_11.
Texto completoParratt, J. R. "Cardioprotective Effects of Iloprost". En Prostacyclin and Its Stable Analogue Iloprost, 301–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71499-3_33.
Texto completoMcDonald, Fiona M. "Cardioprotective Effects of Prostacyclin Analogues". En Prostanoids and Drugs, 71–81. New York, NY: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-7938-6_10.
Texto completoHershko, Chaim, Gabriela Link y Abraham M. Konijn. "Cardioprotective Effect of Iron Chelators". En Iron Chelation Therapy, 77–89. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0593-8_5.
Texto completoMewton, Nathan, François Roubille, Olivier Lairez, Gilles Rioufol, Meyer Elbaz, Christophe Piot y Michel Ovize. "Translating Cardioprotective Strategies into Clinical Settings". En Management of Myocardial Reperfusion Injury, 87–99. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84996-019-9_5.
Texto completoKhan, Aisha Saleem. "Trees with Hepatoprotective and Cardioprotective Activities". En Medicinally Important Trees, 133–57. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56777-8_6.
Texto completoDe Hert, Stefan. "Perioperative Cardioprotective Strategies in Noncardiac Surgery". En Total Intravenous Anesthesia and Target Controlled Infusions, 749–61. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47609-4_41.
Texto completoAlissa, Eman M. y Gordon A. Ferns. "Potential Cardioprotective Effects of Functional Foods". En Functional Foods and Dietary Supplements, 463–87. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118227800.ch17.
Texto completoAl-Harrasi, Ahmed, Saurabh Bhatia, Tapan Behl y Deepak Kaushik. "The Cardioprotective Effects of Essential Oils". En Role of Essential Oils in the Management of COVID-19, 329–58. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003175933-23.
Texto completoLim, Vuanghao, Jun Jie Tan y Yoke Keong Yong. "Kalmegh (Andrographis paniculata) and Cardioprotective Mechanisms". En Ancient and Traditional Foods, Plants, Herbs and Spices used in Cardiovascular Health and Disease, 193–213. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003220329-15.
Texto completoActas de conferencias sobre el tema "Cardioprotective"
Machado, Fernanda, Irene Gómez-Domínguez, Raul Hurtado-Ribeira, Diana Martin, Manuel A. Coimbra, María Dolores del Castillo y Filipe Coreta-Gomes. "Colonic Fermentation of Coffee Melanoidins and Resulting Cardioprotective Metabolites". En ICC 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/icc2023-14836.
Texto completoНгуен, Т. Х. В., Л. Ю. Лагуткина y А. А. Хамад. "USE OF PLANT-DERIVED CARDIOPROTECTIVE COMPONENTS IN COMPOUND FEED FOR STURGEON FISH". En DEVELOPMENT AND MODERN PROBLEMS OF AQUACULTURE. ООО "ДГТУ-Принт" Адресс полиграфического предприятия 344003 пл Гагарина, зд. 1, 2023. http://dx.doi.org/10.23947/aquaculture.2023.86-89.
Texto completoPetrović, Anica, Jovana Bradić, Marijana Andjić, Aleksandar Kočović, Jovana Novaković y Vladimir Jakovljević. "CARDIOPROTECTIVE EFFECTS OF LADY’S BEDSTRAW EXTRACT: FOCUS ON OXIDATIVE STRESS". En 2nd International Symposium on Biotechnology. Faculty of Agronomy in Čačak, University of Kragujevac, 2024. http://dx.doi.org/10.46793/sbt29.75ap.
Texto completoKammerer, Susanne. "No cardioprotective effect of ACE inhibitors in patients with cancer". En ACC 2024 Scientific Session, editado por Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/74e63393.
Texto completoTabima Martinez, Diana Marcela, Victor Bilan, Stevan P. Tofovic y Mark T. Gladwin. "Is Nitrite Cardioprotective In An Obese And Pulmonary Hypertensive Rat Model?" En American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4768.
Texto completoKisel, J., E. Ballard, S. Eui-Sik, N. Hart, S. Srivastava, P. Murphy, P. Marino, S. Kapetanakis y J. Steier. "Cardioprotective medication in Duchenne muscular dystrophy: a single-centre cohort study". En ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.455.
Texto completoOjha, S., S. Azimullah, H. Al Taee y MFN Meeran. "Cardioprotective effect of (-)-α-Bisabolol in animal model of myocardial infarction". En GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608133.
Texto completoAhmad, Taseer, Taous Khan, Abdul Shah, Tahira Tabassum, Sultan Almedhesh, Hamdan Al shehri Al, Alasmary Yahia, Mater Mahnashi y Mohammed Alqahtani. "Cardioprotective effect of juglone on isoproterenol-induced myocardial injury in SD rats". En The 1st International E-Conference on Antioxidants in Health and Disease. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/cahd2020-08916.
Texto completoKisel, J., E. Ballard, E. Suh, N. Hart, S. Kapetanakis, S. Srivastava, P. Marino, P. Murphy y J. Steier. "S124 Cardioprotective medication in Duchenne muscular dystrophy: a single-centre cohort study". En British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2022. http://dx.doi.org/10.1136/thorax-2022-btsabstracts.130.
Texto completoXuan, Yuan, Fu Wei, Qiusheng Zheng, Ju Bao, Xu Bo y Qiusheng Zheng. "Antioxidative and cardioprotective activities of total flavonoids from Moldavian balm (Dracocephalum moldavica L.)". En 2010 International Conference on Bioinformatics and Biomedical Technology (ICBBT 2010). IEEE, 2010. http://dx.doi.org/10.1109/icbbt.2010.5478987.
Texto completoInformes sobre el tema "Cardioprotective"
Garlid, Anders. Mitochondrial Reactive Oxygen Species (ROS): Which ROS is Responsible for Cardioprotective Signaling? Portland State University Library, enero de 2000. http://dx.doi.org/10.15760/etd.1640.
Texto completoHerzinger, Thomas. Effects of the Cardioprotective Drugs Dexrazoxane and ADR-925 on Doxorubicin Induced Ca2+ Release from the Sarcoplasmic Reticulum. Portland State University Library, enero de 2000. http://dx.doi.org/10.15760/etd.6945.
Texto completoLi, Peng y Junjun Liu. Effect of tumor necrosis factor inhibitors on the risk of adverse cardiovascular events in patients with psoriasis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, agosto de 2022. http://dx.doi.org/10.37766/inplasy2022.8.0090.
Texto completoTakeda, Mamoru. Neurophysiological Mechanisms Underlying the Attenuation of Nociceptive and Pathological Pain by Phytochemicals: Clinical Application as Therapeutic Agents. Progress in Neurobiology, abril de 2024. http://dx.doi.org/10.60124/j.pneuro.2024.10.02.
Texto completo